Medical Foods Market Size To Reach $33.49 Billion By 2030

Medical Foods Market Growth & Trends

The global medical foods market size is estimated to reach USD 33.49 billion by 2030, registering to grow at a CAGR of 5.13% from 2025 to 2030 according to a new report by Grand View Research, Inc. Rising geriatric population, prevalence of chronic diseases, a shift toward consuming disease-specific formulas, and a growing demand for neonatal and preterm enteral feeding are some of the factors driving this growth.

The oral route of the administration segment dominated the market in 2024. The major factors contributing to this growth include a high preference for oral medical foods owing to the ease of consumption and high commercial viability of products administered orally. In addition, these foods are available in a variety of forms such as pills, powder, puddings, and pre-thickened products, thereby fueling the segment’s growth.

In 2024, the powder product segment accounted for the largest revenue share. Factors contributing to the growth include the rising application areas of powdered medical foods, ease of administration, and higher commercial viability. The liquid segment is anticipated to grow at the fastest CAGR from 2025 to 2030, owing to the ease of consumption of liquid-based foods for special medical purposes by the pediatric and geriatric population.

The chemotherapy-induced diarrhea emerged as the largest application segment in 2024.. Diarrhea caused by chemotherapy treatment is one of the common problems among cancer patients and the rising prevalence of cancer is one of the major reasons for this increasing the revenue share. For instance, according to the National Cancer Institute statistics, about half of the patients develop diarrhea when treated with chemotherapy agents and the rate can reach 80% with respect to certain chemotherapy agents.

The institutional sales channel segment dominated the market in 2024. Higher penetration and adoption of oral and enteral medical foods in the healthcare institutions such as clinics, hospitals, and care centers and the rising consumption of these products are some of the major factors contributing to the large revenue share. In addition, the rising demand for such products in inpatient facilities and increasing adoption for such products are boosting the market growth.

North America dominated the market with a revenue share of approximately 30% in 2023.. The presence of major players and high revenue generated by them in the region are the key factors contributing to this growth. In addition, strategic developments, the growing prevalence of chronic conditions, and the increasing adoption of medical foods by patients and healthcare professionals are the other factors supporting the growth.

 Request a free sample copy or view report summary: Medical Foods Market Report

Medical Foods Market Report Highlights

• Based on route of administration, the oral segment led the market with the largest revenue share of 72.86% in 2024.

• The powder segment led the market with the largest revenue share of 35.53% in 2024. Medical foods are most widely available in powder form, which can be administered through the oral route or enteral route by mixing milk or water, as advised by the physician.

• Based on application, the cancer segment led the market with the largest revenue share of 12.11% in 2024.

• Based on module, the protein modules segment led the market with the largest revenue share of 12.72% in 2024.

• Based on sales channel, the DTC segment led the market with the largest revenue share of 59.07% in 2024. DTC sales in the medical foods sector allow companies to bypass traditional retail channels and establish a direct relationship with end users.

Medical Foods Market Segmentation

Grand View Research has segmented the global medical foods market based on route of administration, product, application, module, sales channel, and region:

Medical Foods Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral

• Enteral

Medical Foods Product Outlook (Revenue, USD Million, 2018 - 2030)

• Powder

• Pills

• Liquid

• Other

Medical Foods Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Kidney Disease

• Minimal Hepatic Encephalopathy

• Chemotherapy Induced Diarrhoea

• Pathogen Related Infections

• Diabetic Neuropathy

• ADHD

• Depression

• Alzheimer's Disease

• Nutritional Deficiency

• Orphan Diseases

  • Tyrosinemia

  • Eosinophilic Esophagitis

  • FPIES

  • Phenylketonuria

  • MSUD

  • Homocystinuria

  • Others

• Wound Healing

• Chronic Diarrhea

• Constipation Relief

• Protein Booster

• Dysphagia

• Pain Management

• Parkinson's Disease

• Epilepsy

• Other Cancer related treatments

• Severe Protein Allergy

• Cancer

• Cachexia

• Other

Medical Foods Module Outlook (Revenue, USD Million, 2018 - 2030)

• Amino Acid Module

• Protein Module

• Vitamin & Mineral Modules

• Fatty Acid based Modules

• Carbohydrate Modules

• Fiber Modules

• Ketogenic Modules

• Peptide based Modules

• Hypoallergic Modules

• Others (Electrolyte Module, etc.)

Medical Foods Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

• DTC Sales Channel

  • Online Sales

  • Retail Sales

• Institutional Sales

  • Hospitals

  • Others (Long-term Care Facilities, etc.)

Medical Foods Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • South Africa

  • Kuwait

List of Key Players in Medical Foods Market

• Danone

• Nestlé

• Abbott

• Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)

• Primus Pharmaceuticals Inc.

• Fresenius Kabi AG

• Mead Johnson & Company, LLC